MaryCaren Craine

Title: The Innovations of MaryCaren Craine

Introduction

MaryCaren Craine is an accomplished inventor based in Grayslake, IL. He has made significant contributions to the field of assay technology, particularly in the detection of ligands and organisms. His innovative approach has led to the development of a unique patent that enhances the accuracy of assays.

Latest Patents

MaryCaren Craine holds a patent for a Two-site confirmatory assay. This assay utilizes a detector binding protein (DBP) that generates a signal proportional to the amount of ligand or organism bound to it. The presence of the ligand or organism is confirmed through the use of a confirmatory binding protein (CBP), which binds to a second site on the ligand or organism. This method effectively reduces false positives by indicating true presence through a predetermined reduction in signal. In a preferred embodiment, the CBP is a monoclonal antibody, and the organism is derived from Chlamydia species. This innovative approach has the potential to significantly improve diagnostic accuracy.

Career Highlights

MaryCaren Craine is currently employed at Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on developing advanced diagnostic technologies that can benefit public health. His dedication to innovation has positioned him as a valuable asset to the company.

Collaborations

MaryCaren Craine has collaborated with various professionals in his field, including his coworker Lawrence V. Howard. These collaborations have fostered an environment of innovation and have contributed to the advancement of assay technologies.

Conclusion

MaryCaren Craine's contributions to the field of assay technology through his patent for a Two-site confirmatory assay exemplify his commitment to innovation. His work at Abbott Laboratories Corporation continues to impact the healthcare industry positively.